Pliant Therapeutics

0 followers


Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.

Industries

Headquarters

Stage

Employees

Links

Bernard Coulie
President & CEO

Bernard Coulie

Collapse
Éric Lefebvre
Chief Medical Officer
Hans Hull
Chief Business Officer
Lily Cheung
Chief Human Resources Officer
Scott Turner
Chief Scientific Officer
Minnie Kuo
Chief Development Officer
Mike Ouimette
General Counsel & Corporate Secretary
Marzena Jurek
SVP, Development Operations
Shuguang Zhu
SVP, Chemistry, Manufacturing & Controls
Christopher Keenan
VP, Investor Relations & Corporate Communications
Eve-Irene Lepist
VP, Non-Clinical Development
Fernando Rock
VP, Drug Discovery
Monica Sandberg
VP, Regulatory Affairs
Tim Machajewski
VP, Chemistry
Andrew You
VP, Program Team Lead & Portfolio Management